Aclaris Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.274; its P/E ratio is -0.97; Aclaris Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 17.57M	$ 9.28M	$ 994.00K	$ 2.53M	$ 7.75M
Gross Profit	$ 16.84M	$ 8.43M	$ 2.42M	$ 659.00K	$ 6.24M
EBIT	$ -19.77M	$ -14.57M	$ -28.47M	$ -28.16M	$ -27.64M
EBITDA	$ -19.54M	$ -14.35M	$ -28.25M	$ -27.96M	$ -27.45M
Net Income Common Stockholders	$ -19.40M	$ -14.57M	$ -29.57M	$ -28.16M	$ -27.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 119.11M	$ 103.05M	$ 119.78M	$ 170.80M	$ 217.57M
Total Assets	$ 197.41M	$ 218.35M	$ 235.65M	$ 229.71M	$ 254.60M
Total Debt	$ 426.00K	$ 310.00K	$ 458.00K	$ 603.00K	$ 684.00K
Net Debt	$ -118.68M	$ -102.74M	$ -119.32M	$ -170.20M	$ -216.89M
Total Liabilities	$ 40.23M	$ 62.02M	$ 55.90M	$ 52.90M	$ 56.98M
Stockholders Equity	$ 157.18M	$ 156.33M	$ 179.79M	$ 176.78M	$ 197.62M
Cash Flow	-
Free Cash Flow	$ -7.20M	$ -26.94M	$ -19.39M	$ -26.11M	$ -19.22M
Operating Cash Flow	$ -6.76M	$ -26.86M	$ -19.15M	$ -25.55M	$ -19.11M
Investing Cash Flow	$ 7.55M	$ 34.83M	$ -21.16M	$ 25.00M	$ 2.70M
Financing Cash Flow	$ 49.00K	$ -87.00K	$ 26.74M	-	$ 37.00K

Currency in USD

Aclaris Therapeutics Earnings and Revenue History

Income Statement >

Aclaris Therapeutics Debt to Assets

Balance Sheet >

Aclaris Therapeutics Cash Flow

Cash Flow >

Aclaris Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing